Shuni Duan

Donglu, 100029, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Conjugated bile acids facilitate cholangiocyte senescence to promote cholestatic liver diseases via STING signaling.

Conjugated bile acids facilitate cholangiocyte senescence to promote cholestatic liver diseases via STING signaling.

Journal: Journal of advanced research

Published: August 26, 2025

Saikosaponin D exacerbates acetaminophen-induced liver injury by sabotaging GABARAP-SNARE complex assembly in protective autophagy.

Saikosaponin D exacerbates acetaminophen-induced liver injury by sabotaging GABARAP-SNARE complex assembly in protective autophagy.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: October 07, 2024

Precise subcellular organelle-targeted analyses of hepatotoxicity of Polygonum multiflorum.

Precise subcellular organelle-targeted analyses of hepatotoxicity of Polygonum multiflorum.

Journal: Chinese herbal medicines

Published: June 26, 2024

Intestinal epithelial damage-derived mtDNA activates STING-IL12 axis in dendritic cells to promote colitis.

Intestinal epithelial damage-derived mtDNA activates STING-IL12 axis in dendritic cells to promote colitis.

Journal: Theranostics

Published: March 11, 2024

Transcriptotype-Driven Discovery of Apigenin as a Therapy against Cholestatic Liver Fibrosis: Through Inhibition of PANoptosis and Following Type-I Interferon Responses.

Transcriptotype-Driven Discovery of Apigenin as a Therapy against Cholestatic Liver Fibrosis: Through Inhibition of PANoptosis and Following Type-I Interferon Responses.

Journal: Antioxidants (Basel, Switzerland)

Published: November 10, 2023

Saikosaponin D attenuates metabolic associated fatty liver disease by coordinately tuning PPARα and INSIG/SREBP1c pathway.

Saikosaponin D attenuates metabolic associated fatty liver disease by coordinately tuning PPARα and INSIG/SREBP1c pathway.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: April 26, 2022

Targeting bile acid signaling for the treatment of liver diseases: From bench to bed.

Targeting bile acid signaling for the treatment of liver diseases: From bench to bed.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: April 19, 2022

Corrigendum to "Vitexin protects against ethanol-induced liver injury through Sirt1/p53 signaling pathway" [Eur. J. Pharmacol. 873 (2020) 173007].

Corrigendum to "Vitexin protects against ethanol-induced liver injury through Sirt1/p53 signaling pathway" [Eur. J. Pharmacol. 873 (2020) 173007].

Journal: European journal of pharmacology

Published: May 29, 2020

Vitexin protects against ethanol-induced liver injury through Sirt1/p53 signaling pathway.

Vitexin protects against ethanol-induced liver injury through Sirt1/p53 signaling pathway.

Journal: European journal of pharmacology

Published: September 17, 2019

Effect of vitexin on alleviating liver inflammation in a dextran sulfate sodium (DSS)-induced colitis model.

Effect of vitexin on alleviating liver inflammation in a dextran sulfate sodium (DSS)-induced colitis model.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: September 06, 2019

Curcumin attenuates potassium oxonate-induced hyperuricemia and kidney inflammation in mice.

Curcumin attenuates potassium oxonate-induced hyperuricemia and kidney inflammation in mice.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: May 27, 2019

Showing 1-11 of 11

Last Updated: 09/26/2026